References
- Berbel Garcia A, LatorreIbarra A, Porta Etessam J, Martinez Salio A, Perez Martinez D, Siaz Diaz R, Toledo Heras M. Protease inhibitor-induced carbamazepine toxicity. Clin Neuropharmacol 2000; 23: 216–218, [PUBMED], [INFOTRIEVE], [CSA]
- Cui S S, Yang C P, Bowen R C, Bai O, Li X M, Jiang W, Zhang X. Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats. Brain Res 2003; 975: 229–236, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dorsky D I, Harrington R D. An indicator cell assay for T-cell tropic, macrophage-tropic, and primary isolates of HIV-1 based on green fluorescent protein. J Acquir Immune Defic Syndr 1999; 22: 213–220, [PUBMED], [INFOTRIEVE], [CSA]
- Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova L Y, Maggirwar S B, Dewhurst S, Gelbard H A, Gendelman H E. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 2003; 23: 9162–9170, [PUBMED], [INFOTRIEVE], [CSA]
- Halman M H, Worth J L, Sanders K M, Renshaw P F, Murray G B. Anticonvulsant use in the treatment of manic syndromes in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 1993; 5: 430–434, [PUBMED], [INFOTRIEVE], [CSA]
- Hugen P W, Burger D M, Brinkman K, ter Hofstede H J, Schuurman R, Koopmans P P, Hekster Y A. Carbamazepine–indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother 2000; 34: 465–470, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Letendre S L, McCutchan J A, Childers M E, Woods S P, Lazzaretto D, Heaton R K, Grant I, Ellis R J. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 2004; 56: 416–423, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mirsattari S M, Power C, Nath A. Primary headaches with HIV infection. Headache 1999; 39: 3–10, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol 1996; 77: 1993–1999, [PUBMED], [INFOTRIEVE], [CSA]
- Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002; 186(Suppl 2)S193–S198, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Perez V L, Rowe T, Justement J S, Butera S T, June C H, Folks T M. An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation. J Immunol 1991; 147: 3145–3148, [PUBMED], [INFOTRIEVE], [CSA]
- Stingele K, Haas J, Zimmermann T, Stingele R, Hubsch-Muller C, Freitag M, Storch-Hagenlocher B, Hartmann M, Wildemann B. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology 2001; 56: 355–361, [PUBMED], [INFOTRIEVE], [CSA]
- Witvrouw M, Schmit J C, Van Remoortel B, Daelemans D, Este J A, Vandamme A M, Desmyter J, De Clercq E. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retroviruses 1997; 13: 187–192, [PUBMED], [INFOTRIEVE], [CSA]
- Wolfe G I, Barohn R J. Painful peripheral neuropathy. Curr Treat Options Neurol 2002; 4: 177–188, [PUBMED], [INFOTRIEVE], [CSA]
- Wong M C, Suite N D, Labar D R. Seizures in human immunodeficiency virus infection. Arch Neurol 1990; 47: 640–642, [PUBMED], [INFOTRIEVE], [CSA]